Jark Böttcher
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Protein Structure and Dynamics
- PI3K/AKT/mTOR signaling in cancer
Papers in
- Virology 7
- HIV Research and Treatment 7
-
- HIV/AIDS drug development and treatment 9
- Co-authors
- K. Maskos (2 shared papers)Robert Huber (2 shared papers)Lars Neumann (2 shared papers)Elisabeth V. Schneider (2 shared papers)Gerhard Klebe (9 shared papers)A. Heine (8 shared papers)Wibke E. Diederich (6 shared papers)Andreas Blum (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)ChemMedChem (5 papers)Journal of Molecular Biology (3 papers)Molecular Cancer Therapeutics (2 papers)Nature Chemical Biology (2 papers)
- Partner nations
- AustriaGermanyUnited Kingdom
In The Last Decade
Jark Böttcher
33 papers receiving 1.6k citations
Jark Böttcher's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 481
- Molecular Biology 1.1k
- Virology 56
- Computational Theory and Mathematics 188
- Cancer Research 110
Countries citing papers authored by Jark Böttcher
This map shows the geographic impact of Jark Böttcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jark Böttcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jark Böttcher more than expected).
Fields of papers citing papers by Jark Böttcher
This network shows the impact of papers produced by Jark Böttcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jark Böttcher. The network helps show where Jark Böttcher may publish in the future.
Co-authors
The 25 scholars most cited alongside Jark Böttcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pan-KRAS inhibitor disables oncogenic signalling and tumour growth Hit paper breakdown → | 2023 | 354 |
| 2 | BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition Hit paper breakdown → | 2020 | 334 |
| 3 | 2011 | 112 | |
| 4 | 2013 | 106 | |
| 5 | 2019 | 78 | |
| 6 | 2022 | 62 | |
| 7 | 2020 | 61 | |
| 8 | 2021 | 51 | |
| 9 | 2020 | 45 | |
| 10 | 2005 | 43 | |
| 11 | 2008 | 42 | |
| 12 | 2021 | 34 | |
| 13 | 2008 | 29 | |
| 14 | 2006 | 28 | |
| 15 | 2005 | 24 | |
| 16 | 2020 | 24 | |
| 17 | 2020 | 22 | |
| 18 | 2021 | 19 | |
| 19 | 2007 | 16 | |
| 20 | 2008 | 16 |
About Jark Böttcher
Jark Böttcher is a scholar working on Virology, Infectious Diseases, Oncology, Molecular Biology and Organic Chemistry, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (7 papers), Ubiquitin and proteasome pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Enzyme Structure and Function (4 papers), Peptidase Inhibition and Analysis (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Protein Structure and Dynamics (3 papers). The work is most often cited by research in Oncology (481 citations), Molecular Biology (1.1k citations), Virology (56 citations), Computational Theory and Mathematics (188 citations) and Cancer Research (110 citations). Jark Böttcher has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include K. Maskos, Robert Huber, Lars Neumann, Elisabeth V. Schneider, Gerhard Klebe, A. Heine, Wibke E. Diederich, Andreas Blum, Michael Blaesse and Gerhard Müller. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Journal of Molecular Biology, Molecular Cancer Therapeutics and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.